Buss W C, Stepanek J, Bennett W M
Department of Pharmacology, University of New Mexico School of Medicine, Albuquerque 87131.
Biochem Pharmacol. 1989 Nov 15;38(22):4085-93. doi: 10.1016/0006-2952(89)90690-4.
In this paper, we report experiments examining the effect of cyclosporine A on "run-off" translation in microsomes isolated from tissues of Sprague-Dawley rats. In microsomes isolated from rat brain, kidney and thymus, cyclosporine A added in vitro in concentrations of up to 100 micrograms/ml did not reduce [3H]L-leucine incorporation relative to controls. A small dose-dependent reduction in [3H]leucine incorporation was observed in microsomes isolated from rat liver when cyclosporine A was added in high concentrations (5 and 6% at 25 and 100 micrograms/ml). However, when cyclosporine A was injected at 50 mg/kg/day for 10 days, [3H]L-leucine incorporation was inhibited 99.9% in microsomes isolated from kidney. The oral administration of cyclosporine A at 50 mg/kg/day for 6-10 days produced a 75% inhibition of incorporation by isolated renal microsomes. These changes were observed in the absence of measurable reductions in "run-off" transcription measured as [3H]UTP incorporation by renal nuclei exposed to cyclosporine A in concentrations of up to 100 micrograms/ml in vitro or isolated from animals given oral cyclosporine A at 50 mg/kg/day for 6 days. Cross-over experiments were performed using microsomes and microsomal supernatant fractions (cell saps) from tissues of animals treated with cyclosporine A and control vehicle. Renal cell sap from cyclosporine A treated animals inhibited [3H]L-leucine incorporation by microsomes isolated from the kidneys or other tissues of animals treated with control vehicle. These experiments demonstrated that a translation inhibitor was present in the cell sap of cyclosporine A treated animals which could directly block translation elongation in microsomes from control animals. When renal cell sap from both control and cyclosporine A treated animals was added to control microsomes, inhibition was still prominent, suggesting the presence of an inhibitor rather than the absence of an elongation factor. Oral administration of cyclosporine A at 50 mg/kg/day for 6 days depressed renal microsomal [3H]L-leucine incorporation equally in male and female rats to 25% of control. The dose-response relationship for microsomal protein synthesis inhibition after 6 days of oral cyclosporine A administration was: 5 mg/kg, 73.7% of control; 10 mg/kg, 64.1% of control; 25 mg/kg, 54.9% of control and 50 mg/kg, 24.1% of control. Renal microsomal protein synthesis following oral cyclosporine A at 50 mg/kg/day was reduced to 54% of control by day 2 and was maximally inhibited at 25-30% of control by day 4.(ABSTRACT TRUNCATED AT 400 WORDS)
在本文中,我们报告了关于研究环孢素A对从Sprague-Dawley大鼠组织分离出的微粒体中“连续”翻译的影响的实验。在从大鼠脑、肾和胸腺分离出的微粒体中,体外添加浓度高达100微克/毫升的环孢素A相对于对照组并未降低[3H]L-亮氨酸掺入量。当以高浓度(25和100微克/毫升时分别为5%和6%)添加环孢素A时,在从大鼠肝脏分离出的微粒体中观察到[3H]亮氨酸掺入量有小的剂量依赖性降低。然而,当以50毫克/千克/天的剂量注射环孢素A,持续10天时,从肾脏分离出的微粒体中[3H]L-亮氨酸掺入量被抑制了99.9%。以50毫克/千克/天的剂量口服环孢素A,持续6 - 10天,可使分离出的肾微粒体的掺入量受到75%的抑制。在体外以高达100微克/毫升的浓度暴露于环孢素A的肾细胞核或从以50毫克/千克/天的剂量口服环孢素A 6天的动物分离出的肾细胞核中,未观察到以[3H]UTP掺入量衡量的“连续”转录有可测量的降低的情况下,出现了这些变化。使用来自用环孢素A和对照赋形剂处理的动物组织的微粒体和微粒体上清液部分(细胞液)进行了交叉实验。来自用环孢素A处理的动物的肾细胞液抑制了从用对照赋形剂处理的动物的肾脏或其他组织分离出的微粒体的[3H]L-亮氨酸掺入。这些实验表明,在用环孢素A处理的动物的细胞液中存在一种翻译抑制剂,它可以直接阻断来自对照动物的微粒体中的翻译延伸。当将来自对照动物和用环孢素A处理的动物的肾细胞液都添加到对照微粒体中时,抑制仍然很显著,这表明存在一种抑制剂而不是缺乏延伸因子。以50毫克/千克/天的剂量口服环孢素A 6天,雄性和雌性大鼠的肾微粒体[3H]L-亮氨酸掺入量均同等程度地降低至对照的25%。口服环孢素A 6天后微粒体蛋白质合成抑制的剂量反应关系为:5毫克/千克,为对照值的73.7%;10毫克/千克,为对照值的64.1%;25毫克/千克,为对照值的54.9%;50毫克/千克,为对照值的24.1%。以50毫克/千克/天的剂量口服环孢素A后,肾微粒体蛋白质合成在第2天时降至对照值的54%,并在第4天时最大程度地被抑制至对照值的25 - 30%。(摘要截短至400字)